[HTML][HTML] Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine
C Castaneda, K Nalley, C Mannion… - Journal of clinical …, 2015 - Springer
As research laboratories and clinics collaborate to achieve precision medicine, both
communities are required to understand mandated electronic health/medical record …
communities are required to understand mandated electronic health/medical record …
[PDF][PDF] Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries
SL Goldberg, E Chen, M Corral, A Guo, N Mody-Patel… - J Clin Oncol, 2010 - academia.edu
Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States
Medicare Beneficiaries Page 1 Incidence and Clinical Complications of Myelodysplastic …
Medicare Beneficiaries Page 1 Incidence and Clinical Complications of Myelodysplastic …
[HTML][HTML] Protein calorie malnutrition, nutritional intervention and personalized cancer care
Cancer patients often experience weight loss caused by protein calorie malnutrition (PCM)
during the course of the disease or treatment. PCM is expressed as severe if the patient has …
during the course of the disease or treatment. PCM is expressed as severe if the patient has …
[HTML][HTML] Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq …
MB Atkins, SJ Lee, B Chmielowski… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
PURPOSE Combination programmed cell death protein 1/cytotoxic T-cell lymphocyte-4–
blockade and dual BRAF/MEK inhibition have each shown significant clinical benefit in …
blockade and dual BRAF/MEK inhibition have each shown significant clinical benefit in …
[HTML][HTML] Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor,
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …
[PDF][PDF] Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
AL Pecora, N Rizvi, GI Cohen, NJ Meropol… - Journal of Clinical …, 2002 - Citeseer
Patients and Methods: Seventy-nine patients with advanced solid cancers that were
unresponsive to standard therapy were enrolled. Four PV701 intravenous dosing regimens …
unresponsive to standard therapy were enrolled. Four PV701 intravenous dosing regimens …
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
Interleukin-7 (IL-7) is a homeostatic cytokine for resting T cells with increasing serum and
tissue levels during T cell depletion. In preclinical studies, IL-7 therapy exerts marked …
tissue levels during T cell depletion. In preclinical studies, IL-7 therapy exerts marked …
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
K Van Besien, FR Loberiza Jr, R Bajorunaite… - Blood, 2003 - ashpublications.org
In this article, we report on 904 patients undergoing transplantation for follicular lymphoma.
A total of 176 (19%) received allogeneic, 131 (14%) received purged autologous, and 597 …
A total of 176 (19%) received allogeneic, 131 (14%) received purged autologous, and 597 …
[HTML][HTML] Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—an observational study
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an
inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this …
inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this …
A paradigm for consensus: the University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions
LC Vermeulen, TA Ratko, BL Erstad… - Archives of internal …, 1995 - jamanetwork.com
Objective: To develop contemporary, comprehensive guidelines for the appropriate and
efficient use of albumin, nonprotein colloid, and crystalloid solutions. Design: A systematic …
efficient use of albumin, nonprotein colloid, and crystalloid solutions. Design: A systematic …